Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiangiogenesis therapy. Current and future agents.

M W Kieran1, A Billett

  • 1Dana-Farber Cancer Institute, Harvard Medical School Boston, Massachusetts, USA. mkieran@dfci.harvard.edu

Hematology/Oncology Clinics of North America
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.

AJNR. American journal of neuroradiology·2020
Same author

Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome.

Bone·2019
Same author

Multiparametric Analysis of Permeability and ADC Histogram Metrics for Classification of Pediatric Brain Tumors by Tumor Grade.

AJNR. American journal of neuroradiology·2018
Same author

Increasing breastfeeding and reducing smoking in pregnancy: a social marketing success improving life chances for children.

Perspectives in public health·2009
Same author

Moyamoya following cranial irradiation for primary brain tumors in children.

Neurology·2007
Same author

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.

Cancer gene therapy·2006

Targeting tumor blood supply through anti-angiogenesis offers new cancer treatment strategies. This review explores advancements in understanding angiogenesis and its therapeutic potential, particularly for pediatric cancers.

Area of Science:

  • Oncology
  • Cancer Biology
  • Medical Research

Background:

  • Traditional cancer therapies (surgery, radiation, chemotherapy) have seen limited evolution over 50 years.
  • The concept of tumor angiogenesis, the formation of new blood vessels to feed tumors, was introduced in the 1970s.
  • Early therapeutic potential of targeting tumor vasculature was not widely recognized.

Purpose of the Study:

  • To review the current understanding of angiogenesis in cancer biology.
  • To discuss novel therapeutic strategies targeting tumor angiogenesis.
  • To focus on the application and potential of anti-angiogenic therapies in pediatric tumors.

Main Methods:

  • Literature review of scientific articles on tumor angiogenesis.
  • Analysis of molecular mechanisms regulating tumor blood supply.

Related Experiment Videos

  • Discussion of emerging therapeutic agents and their clinical applications.

    • Main Results:

    • Significant scientific interest and excitement surround advances in understanding and targeting tumor angiogenesis.
    • Novel agents are being developed to interfere with the molecular processes of tumor vascularization.
    • This review highlights the potential for treating various cancers, with a specific emphasis on pediatric malignancies.

    Conclusions:

    • Targeting tumor angiogenesis represents a promising frontier in cancer therapy.
    • Further research and clinical trials are crucial for optimizing anti-angiogenic treatments.
    • Anti-angiogenic approaches hold significant potential for improving outcomes in pediatric cancer patients.